000			01517nam a2200337Ia 4500
001			304507
005			20160527184916.0
008			110526s2011 dcua r f000 0 eng d
020			_a9780160886980
020			_a0160886988
035			_a(OCoLC)727126042
040			_aPUCPR
049			_acicdf
050	1	4	_aKF27 _b.W344 2006f
074			_a1028-A
086	0		_aY 4.W 36:109-84
088			_aSerial no. 109-84 (United States. Congress. House. Committee on Ways and Means)
110	2		_aUnited States _bCongress. _bHouse. _bCommittee on Ways and Means. _bSubcommittee on Health. _9182913 _2Local
245	1	0	_aImplementation of the Medicare drug benefit _bhearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, second session,May 3 and May 4, 2006.
260			_aWashington _bU.S. G.P.O. _bFor sale by the Supt. of Docs., U.S. G.P.O. _c2011.
300			_aiv, 227 p. _bill. _c24 cm.
500			_aShipping list no.: 2011-0313-P.
500			_a"Serial no. 109-84."
504			_aIncludes bibliographical references.
650		0	_aPharmaceutical services insurance _zUnited States. _9150480 _2Local
650	0	0	_aMedicare _9134458 _2Local
650	0	0	_aPrescription pricing _zUnited States. _9153548 _2Local
650		0	_aOlder people _xPharmaceutical assistance _zUnited States. _9144748 _2Local
856	4	1	_uhttp://purl.fdlp.gov/GPO/gpo7769
856	4	1	_uhttp://www.gpo.gov/fdsys/pkg/CHRG-109hhrg63132/pdf/CHRG-109hhrg63132.pdf
999			_c223080 _d223080